Patents by Inventor Charles Arthur Bunnell

Charles Arthur Bunnell has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • 2-methyl-thieno-benzodiazepine formulation
    Patent number: 6169084
    Abstract: The invention provides a pharmaceutically acceptable oleaginous or cholesterol microsphere formulation of olanzapine or olanzapine pamoate or solvates thereof. The invention further provides novel olanzapine pamoate salts or solvates thereof.
    Type: Grant
    Filed: September 30, 1998
    Date of Patent: January 2, 2001
    Assignee: Eli Lilly and Company
    Inventors: Charles Arthur Bunnell, Thomas Harry Ferguson, Barry Arnold Hendriksen, Manuel Vicente Sanchez-Felix, David Edward Tupper
  • Intermediates and process for preparing olanzapine
    Patent number: 6020487
    Abstract: The present invention provides a process for preparing olanzapine and intermediates therefor.
    Type: Grant
    Filed: September 23, 1997
    Date of Patent: February 1, 2000
    Assignee: Eli Lilly and Company
    Inventors: Charles Arthur Bunnell, Samuel Dean Larsen, John Richard Nichols, Susan Marie Reutzel, Gregory Alan Stephenson
  • Olanzapine polymorph crystal form
    Patent number: 5736541
    Abstract: The invention provides Form II, a pharmaceutically elegant, stable polymorph of olanzapine useful for treating a condition selected from the group consisting of a psychotic condition, mild anxiety and gastrointestinal conditions.
    Type: Grant
    Filed: July 25, 1996
    Date of Patent: April 7, 1998
    Assignees: Eli Lilly and Company, Eli Lilly and Company
    Inventors: Charles Arthur Bunnell, Barry Arnold Hendriksen, Samuel Dean Larsen